General

Lupin Neurosciences is committed to working with Healthcare Professionals to develop science-based solutions that stretch beyond access to lifechanging treatment options to optimize patient care in underserved neurological diseases.
Transparency Reporting

Transparent collaboration with the healthcare community and patients is key to building trust and respect between the Pharmaceutical industry and the vast spectrum of health-related stakeholders.

As a member of Medicines for Europe, Lupin is committed to meeting all transparency requirements outlined in the Medicines for Europe Code of Conduct. All transfer of value to Healthcare Professionals and organizations, as well as Patient Organizations are recorded and reported on Lupin’s Global website, which can be accessed here.